Cromossomo launches US$2 billion DASA tender offer

Lefosse Advogados has advised Cromossomo, the investment vehicle of two controlling shareholders of Brazilian medical services company Diagnósticos da América (DASA), with a tender offer worth up to US$2 billion to acquire the diagnostics company’s outstanding shares.

Unlock unlimited access to all Latin Lawyer content